COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
18/09/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Update regarding the Market Authorization Application of Apealea in the European Union
18/09/2018
With reference to yesterday’s communicated agenda for this week’s meeting by the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency (EMA) has informed Oasmia Pharmaceutical that no oral [...]
Solon Eiendom ASA – Primary insider notification
18/09/2018
(Oslo, Norway, September 17, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 15.000 shares in Solon Eiendom ASA at a price of NOK 29.16. Following [...]
Shire plc: Rule 2.9 Announcement
18/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 September 2018 [...]
Annonucement no. 7/2018 - Coloplast Capital Markets Day 2018
18/09/2018
Announcement No. 7/2018 18 September 2018 Coloplast Capital Markets Day 2018 Coloplast is hosting a Capital Markets Day in Humlebæk today at 8:15 local time. The purpose of this event is to provide institutional [...]
VIFOR PHARMA GROUP INCREASES EQUITY INVESTMENT IN CHEMOCENTRYX
18/09/2018
Vifor Pharma Group increases equity stake in ChemoCentryx from 6.6% to 21.2%. Vifor Pharma Group acquires an additional 7,343,492 common shares of ChemoCentryx, Inc. (NASDAQ: CCXI) from GlaxoSmithKline - an additional [...]
Orphazyme to Present at InvestorDagen 2018
18/09/2018
Orphazyme A/S Investor news No. 10/2018 Company Registration No. 32266355 Copenhagen, September 18, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
Philippe Ugnat, LLB joins VANC Pharmaceuticals Inc. as Stratregic Advisor
18/09/2018
VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) is pleased to announce the appointment of Philippe Ugnat as Strategic Advisor to help drive the [...]
WHILL, Inc. Raises $45 Million In Funding
18/09/2018
Accelerating global expansion and to fund MaaS business growth SAN CARLOS, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- WHILL, Inc., the innovative company behind the award-winning, next-generation Personal Electric [...]
MPX Provides Update on GreenMart of Nevada NLV LLC
18/09/2018
TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today provided a short update on its GreenMart of Nevada NLV, LLC (“ GreenMart NV ”) operations [...]
Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018
17/09/2018
COLUMBIA, Md., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime
17/09/2018
From a sample of over 10,000 adults, 62% are worried that they may develop Alzheimer's disease and 91% believe the solution to tackling diseases lies in medical research[1] 79% are willing to take part in medical [...]
Retrophin to Present at Upcoming Investor Conferences
17/09/2018
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the Company’s management team will present at the following upcoming investor conferences in October: Cantor Global [...]
argenx announces launch of proposed public offering in the United States
17/09/2018
Regulated information - Inside information September 17, 2018, 10:00 PM CEST - 4:00 PM ET Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing [...]
Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares
17/09/2018
BURNABY, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced the closing of its previously [...]
Ascendis Pharma A/S Announces Support for Children’s Growth Awareness Week and Day 2018
17/09/2018
COPENHAGEN, Denmark, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]
Galapagos issues new shares as result of public offering
17/09/2018
Mechelen, Belgium; 17 September 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase as a result of a public offering of American Depositary Shares. In [...]
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
17/09/2018
Mechelen, Belgium, 17 September 2018, 22.01 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the closing of its underwritten public offering of 2,961,373 American Depositary Shares [...]
EPSi announces partnership with Ilerasoft
17/09/2018
Adds innovative software technology for hospital capital budgeting to EPSi Platform CHICAGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range planning, cost accounting [...]

Pages